Search Results - A. M. Shutov

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Chronic kidney disease in older patients: the contribution of kidney pathology to the estimated glomerular filtration by E. V. Efremova, A. M. Shutov, T. S. Kuznetsovа

    Published 2024-04-01

    The purpose of the study was to assess the contribution of kidney pathology to the estimated glomerular filtration rate and its prognostic value in elderly and senile patients.Materials and methods. 472 elderly and senile age patients (241 women and 231 men, mean age 69.6±7.3 years) with stable card...

    Full description

    Get full text
    Article
  2. 2

    Personal Characteristics and Adaptation Mechanisms of Patients with Arterial Hypertension and Chronic Heart Failure by E. V. Efremova, A. M. Shutov, E. V. Petrova

    Published 2021-01-01

    Adaptation processes in chronic diseases, including arterial hypertension (AH) and chronic heart failure (CHF), depend both on the personality of the patient and on comorbidity. Objective: to study the characteristics of adaptation and mental functioning of patients with hypertension and heart failu...

    Full description

    Get full text
    Article
  3. 3

    Comorbidity, multimorbidity, dual diagnosis — synonyms or different terms? by O. M. Drapkina, A. M. Shutov, E. V. Efremova

    Published 2019-04-01

    The authors express their opinion on the problem of the terminology of the combined pathology in modern clinical practice. The terms “comorbidity”, “multimorbidity”, “dual diagnosis” are considered in terms of conceptual differences. The issues of diagnostics, classification and modern clinical reco...

    Full description

    Get full text
    Article
  4. 4

    Modern concept — renal continuum (acute kidney injury, acute kidney disease, chronic kidney disease) by A. M. Shutov, E. V. Efremova, M. V. Menzorov, V. A. Serov, A. A. Samoshilova

    Published 2021-03-01

    The lectures present the current understanding of the renal continuum, reflecting the relationship between acute kidney injury (AKI), acute kidney disease (AKD) and chronic kidney disease (CKD). The issue of early diagnosis of AKI remains unresolved, despite numerous studies on biomarkers of acute k...

    Full description

    Get full text
    Article
  5. 5

    RISK FACTORS OF ARRHYTHMIAS IN PATIENTS WITH ACUTE DECOMPENSATION OF CHRONIC HEART FAILURE by N. V. Larionova, A. M. Shutov, M. V. Menzorov, E. V. Efremova, V. V. Kasalinskaya

    Published 2017-09-01

    The aim of the research. The aim of this study was to investigate risk factors of arrhythmias, the frequency of acute kidney injury (AKI) in patients with acute decompensation of chronic heart failure (ADCHF) and AKI impact on dynamics of electrocardiographic parameters. Materials and methods.103 pa...

    Full description

    Get full text
    Article
  6. 6

    THE CASE OF INFARCTED DEBUT OF GUILLAIN-BARRE SYNDROME by A. M. Shutov, M. V. Menzorov, E. V. Efremova, E. R. Makeyeva, E. V. Mikhailova

    Published 2015-10-01

    Differential diagnosis of acute myocardial infarction is still raised many questions, despite advances in modern medicine. This clinical situation demonstrates the complexity and ambiguity of diagnosis infarcted debut of Guillain-Barre syndrome.

    Get full text
    Article
  7. 7

    CASE OF GUILLAIN-BARRE´ SYNDROME IN A PATIENT WITH PULMONARY LANGERHANS CELL HYSTIOCYTOSIS by E. V. Efremova, A. V. Vasil’chev, A. M. Shutov, A. S. Podusov, I. Yu Troshina, A. A. Timofeev

    Published 2019-10-01

    Langerhans cell histiocytosis is a rare disease characterized by various clinical patterns: from isolated lung lesions to severe involvement of other organs. This clinical case demonstrates a rare combination of pulmonary Langerhans cell histiocytosis and Guillain—Barre syndrome due to possible comm...

    Full description

    Get full text
    Article
  8. 8
  9. 9

    Approaches to the therapy of heart failure with reduced ejection fraction. Resolution of an online meeting of the Volga Federal District experts by A. S. Galyavich, I. V. Fomin, I. R. Gaisin, F. V. Valeeva, N. G. Vinogradova, A. S. Salasyuk, E. I. Tarlovskaya, N. R. Khasanov, A. M. Shutov, E. N. Volodina, L. V. Grekhova, P. S. Guseva, D. V. Duplyakov, O. V. Zanozina, Yu. V. Zolotova, S. V. Kanysheva, Z. F. Kim, S. K. Kononov, V. P. Kuzmin, S. S. Markiyanova, M. V. Menzorov, S. A. Pomosov, A. P. Rebrov, S. N. Tolstov

    Published 2022-02-01

    At an online meeting of experts held on May 14, 2021 additional research results on a sodium-glucose co-transporter-2 (SGLT2) inhibitor empagliflozin in patients with heart failure with reduced ejection fraction were considered. According to the data from the EMPEROR-Reduced international study, car...

    Full description

    Get full text
    Article
  10. 10

    Resolution of an online meeting of the Volga Federal District experts on the EMPEROR-Reduced trial “A new era in the treatment of patients with HF. From EMPA-REG OUTCOME to EMPEROR... by S. V. Villevalde, A. S. Galyavich, N. G. Vinogradova, E. N. Volodina, I. R. Gaisin, S. R. Gilyarevsky, L. V. Grekhova, Yu. A. Guryanova, P. S. Guseva, D. V. Duplyakov, A. V. Ezhov, N. E. Zakirova, Yu. V. Zolotova, A. V. Isakov, S. V. Kanysheva, Z. F. Kim, V. P. Kuzmin, S. S. Markiyanova, S. A. Pomosov, A. P. Rebrov, E. I. Tarlovskaya, S. N. Tolstov, I. V. Fomin, N. R. Khasanov, A. M. Shutov

    Published 2021-07-01

    An online meeting of experts held on November 6, 2020 describes the results of EMPA-REG OUTCOME and EMPEROR-Reduced trials on sodium-glucose co-transporter-2 (SGLT2) inhibitor empagliflozin. We analyzed cardiovascular and renal outcomes in patients with and without type 2 diabetes (T2D) receiving em...

    Full description

    Get full text
    Article
  11. 11